- Home
- ALDX vs POWW Comparison
ALDX vs POWW Comparison
Compare ALDX & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- POWW
- Stock Information
- Founded
- ALDX 2004
- POWW 1990
- Country
- ALDX United States
- POWW United States
- Employees
- ALDX N/A
- POWW N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- POWW Ordnance And Accessories
- Sector
- ALDX Health Care
- POWW Industrials
- Exchange
- ALDX Nasdaq
- POWW Nasdaq
- Market Cap
- ALDX 160.8M
- POWW 155.4M
- IPO Year
- ALDX 2014
- POWW N/A
- Fundamental
- Price
- ALDX $4.76
- POWW $1.20
- Analyst Decision
- ALDX Strong Buy
- POWW Buy
- Analyst Count
- ALDX 2
- POWW 2
- Target Price
- ALDX $9.50
- POWW $1.75
- AVG Volume (30 Days)
- ALDX 1.2M
- POWW 586.6K
- Earning Date
- ALDX 07-31-2025
- POWW 08-24-2025
- Dividend Yield
- ALDX N/A
- POWW N/A
- EPS Growth
- ALDX N/A
- POWW N/A
- EPS
- ALDX N/A
- POWW N/A
- Revenue
- ALDX N/A
- POWW $44,429,095.00
- Revenue This Year
- ALDX N/A
- POWW $123.84
- Revenue Next Year
- ALDX N/A
- POWW N/A
- P/E Ratio
- ALDX N/A
- POWW N/A
- Revenue Growth
- ALDX N/A
- POWW N/A
- 52 Week Low
- ALDX $1.14
- POWW $0.95
- 52 Week High
- ALDX $7.20
- POWW $2.14
- Technical
- Relative Strength Index (RSI)
- ALDX 78.74
- POWW 31.78
- Support Level
- ALDX $4.12
- POWW $1.27
- Resistance Level
- ALDX $4.60
- POWW $1.35
- Average True Range (ATR)
- ALDX 0.29
- POWW 0.05
- MACD
- ALDX 0.08
- POWW 0.00
- Stochastic Oscillator
- ALDX 90.91
- POWW 10.53
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.